| Santa Marya Family Medicine Clinic,inc | |
|
3400 W Ball Rd Suite 202 Anaheim CA 92804-3735 | |
| (714) 236-9663 | |
| Not Available |
| Full Name | Santa Marya Family Medicine Clinic,inc |
|---|---|
| Speciality | Clinic/Center |
| Location | 3400 W Ball Rd, Anaheim, California |
| Authorized Official Name and Position | Catherine Marks (MD. PRESIDENT) |
| Authorized Official Contact | 7142369663 |
| Accepts Medicare Insurance | Yes. This clinic participates in medicare program and accept medicare insurance. |
| Mailing Address | Practice Location Address |
|---|---|
| Santa Marya Family Medicine Clinic,inc 3400 W Ball Rd Suite 202 Anaheim CA 92804-3735 Ph: (714) 236-9663 | Santa Marya Family Medicine Clinic,inc 3400 W Ball Rd Suite 202 Anaheim CA 92804-3735 Ph: (714) 236-9663 |
| NPI Number | 1245620442 |
|---|---|
| Provider Enumeration Date | 01/27/2015 |
| Last Update Date | 04/03/2015 |
| Medicare PECOS PAC ID | 1951628338 |
|---|---|
| Medicare Enrollment ID | O20150324000435 |
News Archive
3SBio Inc., a leading biotechnology company focused on researching, developing, manufacturing and marketing biopharmaceutical products primarily in China, today announced that it has submitted its application for a registrational clinical trial to the Chinese State Food and Drug Administration ("SFDA") for Feraheme (ferumoxytol) Injection for intravenous use.
Newly released "estimates of maternal mortality from the United Nations' Maternal Mortality Estimation Inter-Agency Group (MMEIG) are good news – but not good enough," Peter Byass, professor of global health at Umea University in Sweden and director of the Umea Centre for Global Health Research, writes in this post in the PLoS "Speaking of Medicine" blog.
A technique that enables patients suffering from heart conditions to hold their breath safely for over 5 minutes could have potential as part of a new treatment for cardiac arrhythmias, say researchers at the University of Birmingham.
Researchers at SUNY Downstate Medical Center in Brooklyn have determined that low levels of a protein in the blood is a predictor of cardiac death in patients with coronary artery disease.
› Verified 4 days ago
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1245620442 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 261Q00000X | Clinic/center | (* (Not Available)) | Primary |
| Provider Name | Assanassios Moussa Faltas |
|---|---|
| Provider Type | Practitioner - Family Practice |
| Provider Identifiers | NPI Number: 1366833899 PECOS PAC ID: 4688991060 Enrollment ID: I20150325001219 |
News Archive
3SBio Inc., a leading biotechnology company focused on researching, developing, manufacturing and marketing biopharmaceutical products primarily in China, today announced that it has submitted its application for a registrational clinical trial to the Chinese State Food and Drug Administration ("SFDA") for Feraheme (ferumoxytol) Injection for intravenous use.
Newly released "estimates of maternal mortality from the United Nations' Maternal Mortality Estimation Inter-Agency Group (MMEIG) are good news – but not good enough," Peter Byass, professor of global health at Umea University in Sweden and director of the Umea Centre for Global Health Research, writes in this post in the PLoS "Speaking of Medicine" blog.
A technique that enables patients suffering from heart conditions to hold their breath safely for over 5 minutes could have potential as part of a new treatment for cardiac arrhythmias, say researchers at the University of Birmingham.
Researchers at SUNY Downstate Medical Center in Brooklyn have determined that low levels of a protein in the blood is a predictor of cardiac death in patients with coronary artery disease.
› Verified 4 days ago
| Provider Name | Catherine Marks |
|---|---|
| Provider Type | Practitioner - Family Practice |
| Provider Identifiers | NPI Number: 1801214788 PECOS PAC ID: 6406173889 Enrollment ID: I20150325001555 |
News Archive
3SBio Inc., a leading biotechnology company focused on researching, developing, manufacturing and marketing biopharmaceutical products primarily in China, today announced that it has submitted its application for a registrational clinical trial to the Chinese State Food and Drug Administration ("SFDA") for Feraheme (ferumoxytol) Injection for intravenous use.
Newly released "estimates of maternal mortality from the United Nations' Maternal Mortality Estimation Inter-Agency Group (MMEIG) are good news – but not good enough," Peter Byass, professor of global health at Umea University in Sweden and director of the Umea Centre for Global Health Research, writes in this post in the PLoS "Speaking of Medicine" blog.
A technique that enables patients suffering from heart conditions to hold their breath safely for over 5 minutes could have potential as part of a new treatment for cardiac arrhythmias, say researchers at the University of Birmingham.
Researchers at SUNY Downstate Medical Center in Brooklyn have determined that low levels of a protein in the blood is a predictor of cardiac death in patients with coronary artery disease.
› Verified 4 days ago
News Archive
3SBio Inc., a leading biotechnology company focused on researching, developing, manufacturing and marketing biopharmaceutical products primarily in China, today announced that it has submitted its application for a registrational clinical trial to the Chinese State Food and Drug Administration ("SFDA") for Feraheme (ferumoxytol) Injection for intravenous use.
Newly released "estimates of maternal mortality from the United Nations' Maternal Mortality Estimation Inter-Agency Group (MMEIG) are good news – but not good enough," Peter Byass, professor of global health at Umea University in Sweden and director of the Umea Centre for Global Health Research, writes in this post in the PLoS "Speaking of Medicine" blog.
A technique that enables patients suffering from heart conditions to hold their breath safely for over 5 minutes could have potential as part of a new treatment for cardiac arrhythmias, say researchers at the University of Birmingham.
Researchers at SUNY Downstate Medical Center in Brooklyn have determined that low levels of a protein in the blood is a predictor of cardiac death in patients with coronary artery disease.
› Verified 4 days ago
The Family Medicine Center Primary Care Clinic Medicare: Not Enrolled in Medicare Practice Location: 1211 W. La Palma Avenue, Suite #404, Anaheim, CA 92801 Phone: 714-772-1030 Fax: 714-772-1758 | |
Anaheim Medical Group Inc Primary Care Clinic Medicare: Medicare Enrolled Practice Location: 2571 W La Palma Ave, Anaheim, CA 92801 Phone: 714-827-9797 Fax: 714-827-5377 | |
Shirdi Medical Corporation Primary Care Clinic Medicare: Not Enrolled in Medicare Practice Location: 1751 W Romneya Dr, Anaheim, CA 92801 Phone: 714-776-3180 Fax: 714-991-1932 | |
Rakesh Kumar Bhola ,m.d. Inc Primary Care Clinic Medicare: Medicare Enrolled Practice Location: 1781 W Romneya Dr Ste C, Anaheim, CA 92801 Phone: 714-776-2700 | |
Anaheim Health Care Center Primary Care Clinic Medicare: Not Enrolled in Medicare Practice Location: 1125 N Magnolia Ave, Anaheim, CA 92801 Phone: 714-484-1280 Fax: 714-484-1358 | |
Richard Dick M Yip Md A Medical Corp Primary Care Clinic Medicare: Not Enrolled in Medicare Practice Location: 408 S Beach Blvd Ste 211, Anaheim, CA 92804 Phone: 714-527-6000 Fax: 714-527-2371 | |
Benevolence Health Center Primary Care Clinic Medicare: Medicare Enrolled Practice Location: 303 N East St, Anaheim, CA 92805 Phone: 714-491-1771 |